Emergency & Resuscitation in Arizona

Delta Development Team Inc manufactures specialized transportable blood storage and cold-chain logistics solutions for prehospital, military, first responder, and emergency medical settings. The company is a pioneering supplier of thermal management systems and real-time temperature monitoring platforms designed to maintain blood product viability in austere field conditions. Core products include the Autonomous Portable Refrigeration Unit (APRU) series—battery-powered, rugged refrigerators maintaining 1°C–6°C for extended periods (up to 95 hours on a single charge)—and complementary Smart Blood Coolers with Bluetooth and cellular remote monitoring. The company also offers BloodComm, a cloud-based blood program management system providing real-time temperature tracking, alerts, and cold-chain attestation for regulatory compliance. Additional products in development include larger-capacity transportable blood systems (TBS), blood warming devices (SUBW), and temperature conditioning monitors (TempWatch). Delta Development is FDA-listed, AABB-approved, and holds comprehensive regulatory certifications. The company serves fire departments, EMS agencies, hospitals, military units, and blood banks across the United States, with documented deployments in helicopter EMS and ground-based prehospital programs. Key customers include Austin-Travis County EMS (699+ units transfused as of early 2025), Lehigh Valley Health Network, Northeast Georgia Health System, and multiple regional EMS and fire departments. The company emphasizes rigorous testing, validation, and responsive customer support for life-critical applications.

SynCardia Systems, LLC manufactures the SynCardia Total Artificial Heart (STAH), a clinically proven mechanical circulatory support device for patients with end-stage biventricular heart failure who are cardiac transplant-eligible and at imminent risk of death. The company is a wholly owned subsidiary of Picard Medical Inc. and operates from Tucson, Arizona. The STAH system comprises the implantable total artificial heart unit and two driver systems: the Companion 2 Driver System (for in-hospital and bridge-to-transplant use) and the Freedom Portable Driver System (enabling patient mobility and quality-of-life improvements). SynCardia has completed over 1,300 implants across multiple countries. The STAH is approved for sale in the U.S. and Canada and is indicated as a bridge-to-transplant therapy for patients who cannot be supported by conventional left ventricular assist devices (LVADs) alone or who require biventricular support. The company provides comprehensive clinical education, surgical technique training, patient selection guidance, and 24-hour clinical support to cardiac transplant centers and implanting surgeons. SynCardia maintains an active patient community and support program, documenting over 500 patient-years of post-implant follow-up. The device represents a critical intervention in advanced heart failure management for select patient populations.